Cancer prevention through miRNAs: miR-206 prevents the initiation and progression of hepatocellular carcinoma by attenuating c-MET signaling and cell-cycle progression via cyclin D1 and CDK6.
Cancer prevention through miRNAs: miR-206 prevents the initiation and progression of hepatocellular carcinoma by attenuating c-MET signaling and cell-cycle progression via cyclin D1 and CDK6.
复制标题
DOI：
10.21037/ncri.2018.06.05
复制
发表时间：
2018-06
期刊：
影响因子：
--
通讯作者：
Maxine Umeh-Garcia;C. Sweeney
中科院分区：
文献类型：
--
作者：
Maxine Umeh-Garcia;C. Sweeney
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is one of the most common cancers worldwide, with over 80% of cases diagnosed in developing countries in sub-Sahara Africa and Southeast Asia (1). In the United States alone, HCC incidence has more than tripled over the past three decades due to an increased prevalence of liver cirrhosis, which is the major risk factor for HCC.
